U.S loses HIV patent suit against Gilead Sciences over PrEP
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020.Mike Blake | ReutersA Delaware federal court jury on Tuesday cleared Gilead Sciences of civil claims by the U.S. government that the company violated patents held by the Centers for Disease and Prevention for an HIV prevention drug.The government sued Gilead in 2019, arguing that the company was profiting off CDC patents through the company's sales of Truvada and Descovy, oral medications taken to prevent HIV infection.But…